|
1. Kliegman RM, Stanton B, Geme JS, Schor NF. Nelson Textbook of Pediatrics Elsevier. 20th ed. Amsterdam: Elsevier. 2017; p: 1209. 2. Lin MT, Wu MH. The global epidemiology of Kawasaki disease: Review and future perspectives. Glob Cardiol Sci Pract. 2017 Oct; 2017(3): e201720. DOI: 10.21542/gcsp.2017.20 [ DOI] [ PubMed] 3. Ono R, Hasegawa D. Prevalence and characteristics of Kawasaki disease before and during the COVID-19 pandemic. World J Pediatr. 2021 Apr; 17(2): 215-17. DOI: 10.1007/s12519-021-00412-5 [ DOI] [ PubMed] 4. Toubiana J, Cohen JF, Brice J, Poirault C, Bajolle F, Curtis W, et al. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France. J Clin Immunol. 2021 Apr; 41(3): 526-35. DOI: 10.1007/s10875-020-00941-0 [ DOI] [ PubMed] 5. Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. 2021 Jan; 41(1): 19-32. DOI: 10.1007/s00296-020-04749-4 [ DOI] [ PubMed] 6. Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int. 2007 Aug; 49(4): 421-26. DOI: 10.1111/j.1442-200X.2007.02396.x [ DOI] [ PubMed] 7. Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, et al. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med. 2006 Jul; 160(7): 686-90. DOI: 10.1001/archpedi.160.7.686 [ DOI] [ PubMed] 8. Dionne A, Burns JC, Dahdah N, Tremoulet AH, Gauvreau K, de Ferranti SD, et al. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Pediatrics. 2019 Jun; 143(6): e20183341. DOI: 10.1542/peds.2018-3341 [ DOI] [ PubMed] 9. Friedman KG. Kawasaki Disease. In: Lai WW, Mertens LL, Cohen MS. Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult. 3rd ed. New Jersey: Wiley-Blackwell. 2021. DOI: 10.1002/9781119612858.ch39 [ DOI] 10. Zhu F, Ang JY. 2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease. Curr Infect Dis Rep. 2021; 23(3): 3. ID: covidwho-1084775 [ View at Publisher] 11. Kim SH, Kim JY, Kim GB, Yu JJ, Choi JW. Diagnosis of Coronary Artery Abnormalities in Patients with Kawasaki Disease According to Established Guidelines and Z Score Formulas. J Am Soc Echocardiogr. 2021 Jun; 34(6): 662-72.e3. DOI: 10.1016/j.echo.2021.01.002 [ DOI] [ PubMed] 12. Tsuda E, Hashimoto S. Time Course of Coronary Artery Aneurysms in Kawasaki Disease. J Pediatr. 2021 Mar; 230: 133-39.e2. DOI: 10.1016/j.jpeds.2020.12.004 [ DOI] [ PubMed] 13. Tsuda E, Tsujii N, Hayama Y. Cardiac Events and the Maximum Diameter of Coronary Artery Aneurysms in Kawasaki Disease. J Pediatr. 2017 Sep; 188: 70-74.e1. DOI: 10.1016/j.jpeds.2017.05.055 [ DOI] [ PubMed] |
